Novartis Declares Positive Results From Phase
Glenmark Life Sciences Ltd in India reported a 48% increase in fourth-quarter profit on Thursday, owing to growth in its mainstay business of producing active pharmaceutical ingredients (API) for drugs. The Mumbai-based pharmaceutical company's....
Vedanta Biosciences, a clinical-stage company developing a potential new class of oral therapies based on defined bacterial consortia, announced a $106.5 million funding round to support pivotal-stage development of its lead candidate, VE303,...
Alentis Therapeutics (Alentis), a clinical-stage biotechnology company developing novel treatments for organ fibrosis and CLDN1+ tumours, announced results from its first-in-human phase 1 clinical study of ALE.F02 targeting Claudin-1 (CLDN1)....
The World Health Organisation (WHO) has issued a call for increased implementation of new and existing malaria interventions to save lives on World Malaria Day.Thanks to an ongoing pilot programme coordinated by WHO, nearly 1.5 million children...
On Wednesday, the penultimate day of the sale, Mankind Pharma's initial public offering was subscribed to 87%. Institutional investors subscribed 1.86 times, rich investors 1.02 times, and regular investors 25%. Mankind Pharma distributed Rs 1,298...
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the positive outcome of its arbitration with Tracon Pharmaceuticals (Tracon) relating to (1) the...
Nkure Therapeutics, an NK cell therapy startup, has announced the completion of its pre-Series A round, in which Endiya Partners, Kotak Investment Advisors, Featherlite, and a few angel investors participated. Nkure intends to use the funds to....
As India has the G20 presidency and South Korea is a member of the G20, the Korea Pharmaceuticals & Bio Manufacturers Association (KPBMA) in Seoul has inked a memorandum of understanding (MoU) with India. "The KPBMA has special significance,...
Sun Pharmaceutical Industries announced on Tuesday that it has launched a medication in the country to treat dry eye disease. The Mumbai-based pharmaceutical company announced the launch of Cequa, a novel ophthalmology treatment for patients....
, CDSCO.jpg)
